APTVRTNAODJSGY-UHFFFAOYSA-N
C30H23F2N5O4 — CID 66968571
Data last refreshed: (MolForge compound catalog, from PubChem)
About APTVRTNAODJSGY-UHFFFAOYSA-N
APTVRTNAODJSGY-UHFFFAOYSA-N (PubChem CID 66968571) has the molecular formula C30H23F2N5O4 and a molecular weight of 555.54 g/mol. Its IUPAC name is N-[4-[2-(cyclopropanecarbonylamino)imidazo[1,2-a]pyridin-6-yl]oxy-3-fluorophenyl]-6-(4-fluorophenyl)-5-methyl-1-oxidopyridin-1-ium-2-carboxamide.
Molecular Properties
| Compound Name | APTVRTNAODJSGY-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 66968571 |
| Molecular Formula | C30H23F2N5O4 |
| Molecular Weight | 555.54 g/mol |
| Exact Mass | 555.17 |
| IUPAC Name | N-[4-[2-(cyclopropanecarbonylamino)imidazo[1,2-a]pyridin-6-yl]oxy-3-fluorophenyl]-6-(4-fluorophenyl)-5-methyl-1-oxidopyridin-1-ium-2-carboxamide |
| SMILES | Cc1ccc(C(=O)Nc2ccc(Oc3ccc4nc(NC(=O)C5CC5)cn4c3)c(F)c2)[n+]([O-])c1-c1ccc(F)cc1 |
| InChI | InChI=1S/C30H23F2N5O4/c1-17-2-11-24(37(40)28(17)18-5-7-20(31)8-6-18)30(39)33-21-9-12-25(23(32)14-21)41-22-10-13-27-34-26(16-36(27)15-22)35-29(38)19-3-4-19/h2,5-16,19H,3-4H2,1H3,(H,33,39)(H,35,38) |
| InChIKey | APTVRTNAODJSGY-UHFFFAOYSA-N |
| XLogP | 5.61 |
| TPSA | 111.67 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 555.54 |
| LogP ≤ 5 | 5.61 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'N_oxide', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 66968571 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.